The Artificial Intelligence Academy Freshman Debate Competition FIGHTING [Date: 2021.10.11] MYLIFE Debate people's livelihood to be good, and discuss state affairs to help the world. A wonderful debate is about to begin. Are you ready? The debaters are good at speaking, and the c

2025/05/2718:45:35 hotcomm 1537

Artificial Intelligence Academy

French Student Debate Competition

FIGHTING

【Date: 2021.10.11】htmlm l5

MYLIFE

Defend people's livelihood to be good, discuss state affairs to help the world

A wonderful debate is beginning

Are you ready?

A thousand tactics are very good at speaking, and they are infinitely charming

Defenders are 21 students from the Academy of Artificial Intelligence. When they first appeared on the stage of the debate competition, they were not at all stage frightened, but were eager to try. They express their opinions in an orderly manner, enjoy the unique charm of debate from the verbal battle, and all show the colorfulness of their freshman year.

Golden and good words, Rongsihuizhi

In order to develop the self-development ability of college students, the school provides a platform for freshmen to communicate and exercise. In more than a month since the start of school, freshmen have been growing step by step. This debate is also an opportunity for them. Please wait and see!

Defend to understand thoughts, sit and discuss the truth

This debate started on October 11, and the debaters are ready to go. This time, they will show one stunning scene of the fight between gods and immortals, conveying the torch of the wisdom and passion of the sunshine people.

hotcomm

This allows them to redesign proteins reasonably, thus creating a powerful new vaccine against RSV. A team of researchers, including Jason McLellan, University of Texas at Austin, reported today in the journal Science.

Study: New vaccine against respiratory syncytial virus (RSV) triggers strong immune response

05/29 1481

Health Medical Network/Reporter Lin Yiting reported that a premature baby boy born after only 32 weeks in his mother's belly was discharged from the hospital and had cough and runny nose, similar to cold symptoms. Unexpectedly, the condition worsened rapidly after one day, and de

Premature babies are most afraid of RSV infection! Runny nose, fever may lead to death. Doctor: Can you avoid it after 2 years old

05/29 1187

Making a vaccine against RSV (respiratory syncytial virus) has been a minefield for 50 years, but scientists believe they have found the right balance. "They have designed a version of RSV that is highly attenuated -- weakening its ability to cause disease, but with the ability t

The respiratory syncytial virus vaccine will finally be broken in 50 years!

05/29 1704

Original title: Medical puzzles. Respiratory syncytial virus vaccine is expected to be commercialized? Recently, John R. Mascola, a scientist at the Vaccine Research Center of the National Institute of Health, Bethesda, Maryland, published their latest research in the field of va

Medical Problems Is the Respiratory Syncytial Virus Vaccine expected to be commercialized?

05/29 1890

Respiratory syncytial virus (RSV) is a common respiratory virus. Since RSV-infected cells fuse together to form a large cell structure similar to "synocytes", it is vividly given the name of the respiratory "synocyte" virus. It is understood that respiratory syncytial virus is th

RSV is the primary cause of acute lower respiratory tract infection in children, and effective preventive measures are urgently needed

05/29 1083

RSV infection is one of the main reasons for infancy and young children worldwide [1]. In 2015 alone, 11,000 children under 5 years old died of respiratory syncytial virus infection. It is highly contagious and recurring. Even if infants and young children are cured, they are ver

Break the fog! Unveil the mystery of infants' deadly respiratory syncytial virus disease

05/29 1961

Source: [People's Daily Health Client] On September 16, the European Medicines Agency (EMA) Human Medicine Products Committee (CHMP) recommended the approval of Beyfortus for newborns and infants, helping them prevent RSV lower respiratory tract infections when the first respirat

Sanofi and AstraZeneca jointly develop new drugs, recommended by the EU to prevent syncytial virus

05/29 1149

Recently, the US stock market has been slumping, and the move of sacrifice to the sky is thrilling. What should we do next? Listen to the sheep to tell me carefully.

Sudden storms in the middle of the night - S&P Global and Novavax Pharmaceuticals staged a series of surprise attacks

05/29 1269

Although the COVID-19 epidemic in the United States improved in June 2021, it has not been completely controlled. As of today, the total number of new coronary pneumonia infections in the United States has exceeded 33.7 million, and more than 605,000 deaths.

One wave has not yet settled and another wave has started again! Will the outbreak of the RSV virus in the United States be more serious than the new crown epidemic?

05/29 1198